feed,title,long_url,short_url
Benzinga,Marker Therapeutics Stock Gains On FDA Orphan Drug Tag For Second MultiTAA-Cell Therapy For Pancreatic Cancer,https://benzinga.com/general/biotech/22/01/25128414/marker-therapeutics-stock-gains-on-fda-orphan-drug-tag-for-second-multitaa-cell-therapy-for-pancr,https://bit.ly/32gLVZj
